Mirae Asset Global Investments
SION

Mirae Asset Global Investments’s Sionna Therapeutics SION Stock Holding History

Mirae Asset Global Investments’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.8K Sell
2,019
-309
-13% -$12.4K ﹤0.01% 1259
2026
Q1 		$93.3K Buy
2,328
+159
+7% +$6.07K ﹤0.01% 1196
2025
Q4 		$89.2K Buy
+2,169
New +$82.2K ﹤0.01% 1280

Other funds holding SION

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Mirae Asset Global Investments's SION Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Sionna Therapeutics (SION) stake by 13% in Q2 2026, selling an estimated $12.4K and leaving 2,019 shares worth $88.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1259.

Mirae Asset Global Investments first reported a position in SION in Q4 2025 and has held it in 3 quarters since. The position peaked at $93.3K in Q1 2026. 17 funds tracked by Wall St. Rank hold SION as of Q2 2026.

  • Mirae Asset Global Investments held 2,019 shares of Sionna Therapeutics worth $88.8K as of Q2 2026.
  • Mirae Asset Global Investments sold 309 Sionna Therapeutics shares in Q2 2026, an estimated $12.4K.
  • Sionna Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1259 holding.
  • Mirae Asset Global Investments first reported a position in Sionna Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Mirae Asset Global Investments's Sionna Therapeutics position peaked at $93.3K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.